Agilent Technologies to Sponsor USCAP 2016
News Mar 10, 2016

Agilent Technologies Inc. has announced that it will be a Silver sponsor of USCAP 2016, the annual gathering of the United States and Canadian Academy of Pathology, March 12-18, in Seattle.
The Agilent booth will showcase the company's portfolio of genomics and Dako pathology solutions. The company's Learning Theater, located next to its main booth in the Exhibition Hall, will feature international experts speaking on companion diagnostics, molecular pathology, next-generation sequencing and immunohistochemistry.
Agilent will also introduce a new white paper at USCAP: "Breast Cancer Diagnosis: Past, Present and Future," by pathologists Ping Tang and David G. Hicks of the University of Rochester in New York and Dr. Christine Desmedt of the Jules Bordet Institute in Brussels. The paper provides an overview of the use of immunohistochemistry in diagnosing and treating breast cancer.
"As a leader in companion diagnostics, we are proud to be a Silver sponsor of USCAP," said Jacob Thaysen, president of Agilent's Diagnostics and Genomics Group, which includes the Dako products for cancer diagnostics. "Our participation in the congress exemplifies our lasting commitment to education in pathology for better diagnoses and patient care."
RELATED ARTICLES
New Rapid-fire Method Using Pathology Images & Tumor Data May Help Guide Cancer Therapies
NewsBy combining data on pathology images of 13 types of cancer and correlating that with clinical and genomic data, researchers are able to identify tumor-infiltrating lymphocytes, which will enable cancer specialists to generate tumor-immune information from routinely gathered pathology slides.
READ MOREAn End to "Healthy Obesity"?
NewsA new paper has called for an end to the term "healthy obesity", saying it is misleading and flawed. It calls for further research into why some people can avoid diseases associated with obesity whilst others with the same BMI are affected.
READ MOREA Novel Point-of-Care Assay Developed for Hepatitis C
NewsScientists from the Institut Pasteur and Inserm have developed and validated a rapid, reliable, point-of-care HCV assay.
READ MOREComments | 0 ADD COMMENT
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
Login
You must be logged in to post a comment.